AXL, a member of the Tyro, AXL and Mer (TAM) receptor family of receptor tyrosine kinases is a key regulator of EMT as well as drug resistance to doxorubicin and anti-EGFR therapies in many cancer types37, 38. Here, AXL is linked to cancer.